Dr. Rob Taylor is study director for CellzDirect's in vitro drug metabolism studies, including cytochrome P450 inhibition and induction, and drug-drug interaction studies.
Dr. Taylor received his doctorate from the Molecular Toxicology Interdepartmental Doctoral Program at the University of California at Los Angeles. Under the guidance of Dr. Oliver Hankinson, Dr. Taylor's dissertation focused on elucidating mechanisms of transcription of cytochromes P450, mediated by the aryl hydrocarbon receptor complex. Through his graduate training, Dr. Taylor gained expertise in molecular biology and cytochrome P450 gene induction by xenobiotics. |